Parallel Industries Inc. (EAPH) Stock
Currently, Parallel Industries Inc. does not conduct substantial business operations.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Parallel Industries Inc.
Currently, Parallel Industries Inc. does not conduct substantial business operations. Historically, the company was involved in developing and commercializing various topically applied medications to treat cancer, alongside other therapeutic solutions for a range of medical conditions. Its strategic emphasis has typically covered the entire pharmaceutical process: from development and licensing to manufacturing and marketing of both prescription and over-the-counter products. Established in 1997, the firm is headquartered in Toronto, Canada, and was formerly known as Easton Pharmaceuticals Inc. before rebranding as Parallel Industries Inc. in December 2020.
Parallel Industries Inc. (EAPH) stock trades at $0.00 with a market capitalization of $26899. The stock is valued at a price-to-earnings (P/E) ratio of -0.20, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.
On profitability, Parallel Industries Inc. generates a return on equity (ROE) of -2.69%, return on capital employed of -1.97%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.eastonpharma.com